Allarity Therapeutics, Inc. Other Tax Expense (Benefit)
Allarity Therapeutics, Inc. (ALLR) reported Other Tax Expense (Benefit) of $1.22 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherTaxExpenseBenefit · last filed 2023-08-14
- Allarity Therapeutics, Inc. other tax expense (benefit) for the quarter ending 2022-09-30 was -$5.00K.
- Allarity Therapeutics, Inc. other tax expense (benefit) for the quarter ending 2022-06-30 was -$4.00K.
- Allarity Therapeutics, Inc. other tax expense (benefit) for the quarter ending 2022-03-31 was $1.23M.
- Allarity Therapeutics, Inc. other tax expense (benefit) for fiscal 2020 was $1.45M.
| Period end | Other Tax Expense (Benefit) 3 month | Other Tax Expense (Benefit) 6 month | Other Tax Expense (Benefit) 9 month | Other Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$9.00K derived: sum of 2 quarters · filed 2023-08-14 | $1.22M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.22M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $1.23M 10-Q · filed 2023-05-11 | |||
| 2020-12-31 | $1.45M 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |